Prot# A2181015: A Double-Blind Placebo-Controlled, Parallel Group Design Dose-Ranging Study of Three Doses of Lasofoxifene vs. Placebo for Treatment of Sexual Dysfunction (Arousal Disorder) in Postmenopausal Women

Project: Research project

Project Details

StatusFinished
Effective start/end date5/3/0212/8/06

Funding

  • Pfizer Inc. (A2181015)